公告称，董事一直在积极寻找机会，使集团的业务多元化。董事认为，2022年收购事项乃参与中国房地产投资市场的投资机会，集团将从中国房地产价格的长期升值中获益。Zhongda Group Holdings (00139) issued an announcement. On November 4, 2022, the buyer (a wholly-owned subsidiary of the company...
According to Zhitong Finance App, Zhongda Group Holdings (00139) announced that on November 4, 2022, the buyer (Morley Way Limited, a wholly-owned subsidiary of the company) signed a 2022 sales agreement with seller B Chen Yihao. Seller B agreed to sell and the buyer agreed to buy 2022 sales shares (equivalent to 24% of the target company Senworth Limited's issued share capital), with a total cost of HK$80.64 million.
The target company is a limited company incorporated in Hong Kong, mainly engaged in investment holdings. At the time of entering into the 2022 sales agreement, Seller B, Buyer and two independent third parties owned 25%, 25% and 50% of the shares respectively. The target company holds 90% of Tianshun Property (a limited company established in China). As a result, Tianshun Property holds 50% of Everbright Real Estate (a limited company established in China). Everbright Real Estate holds the right to use the property's land. The property is located on a plot of land in Shantou City, Guangdong Province, China, with a total area of about 44755.57 square meters for real estate development. Land use rights run from March 11, 1998 to November 12, 2066.
The announcement stated that the directors have been actively seeking opportunities to diversify the Group's business. The directors believe that the 2022 acquisition is an investment opportunity to participate in the Chinese real estate investment market, and that the Group will benefit from the long-term appreciation of real estate prices in China.
The directors are optimistic about the long-term development of China's real estate market. Given the property's potential for long-term appreciation in the future, the directors believe it would be beneficial to the Group to invest in shares sold in 2022. In view of the above, directors (including independent non-executive directors) believe that the terms of the 2022 acquisition are fair and reasonable, are based on general commercial terms, and conform to the overall interests of the company and shareholders.